Florida State University
Tallahassee, Florida, 32306, United States
NCT Number: NCT06175299
This study will examine whether among older adults social interaction functions in a home-based cognitive training program can better support adherence to training and reduce social isolation.
Looking for future studies?
Notify Me65 year–90 year
All sexes
Interventional
Not applicable
Tallahassee, Florida, 32306, United States
The goal of this project is to conduct a pilot study to test the feasibility of two new features, a chat function and a leaderboard function, to encourage social interactions and support adherence to cognitive training protocols (mental exercises delivered via a tablet) over a period of time (2 months), and uncover individual difference factors that can predict poor adherence in the future and social interactions in the game. Even effective cognitive interventions may fail if individuals do not adhere to them for an extended period. This project will compare cognitive training games with chat function and leaderboard in reducing social isolation and improving adherence to the training, compared to an external control group using a generic reminder system delivered via smartphone text messages to promote adherence. The ultimate goal, as effective technology-based interventions to improve cognition become available, is to help support their benefit for older adults by maximizing long-term adherence.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The system has seven games for cognitive training and two social interactions functions: a chat function and a leaderboard function.
Time frame: Assessed at baseline and at the end of the 2-months of training
The Three-Item Loneliness Scale was developed by Hughes et al. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394670/). The minimum value is 3. The maximum value is 9. Higher scores mean more loneliness.
Time frame: 2 months
Number of sessions over 2 months
Time frame: 2 months
Number of sessions reaching at least 80% of the assigned session duration over 2 months
Time frame: Assessed at baseline, predicting adherence variables over 2 months
The 10-item General Self-Efficacy Scale (GSE) was developed by Ralf Schwarzer & Matthias Jerusalem (http://userpage.fu-berlin.de/~health/engscal.htm). The minimum value is 10. The minimum value is 40. Higher scores mean higher general self-efficacy.
Time frame: Assessed at baseline
The 7-item Cognitive Training Belief Scale (NICT scale) measures perceived usefulness of brain training. It was developed by Rabipour & Davidson in 2015 (https://pubmed.ncbi.nlm.nih.gov/25591472/). The minimum value is 7. The maximum value is 49. High scores mean higher expectations of brain training efficacy.
Time frame: Assessed at baseline and at the end of the 2-months of training
The 12-item Self-Efficacy of Cognitive Training is a composite measure of self-efficacy of cognitive training based on the Health Belief Model. The minimum value is 12. The maximum value is 84. Higher scores mean lower confidence in computerized cognitive training.
Florida State University
Other
Evaluating the Social Functions to Promote the Adherence and Reduce Social Isolation in Home-based Cognitive Training
Acronym: DeepCare
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05378399
Adherence, Medication, Adherence, Treatment
Boston, Massachusetts, United States
View Trial DetailsNCT06493214
Adherence, Treatment, Behavior
Ann Arbor, Michigan, United States
View Trial DetailsNCT06229873
Adherence, Treatment, Behavior
Boulder, Colorado, United States
View Trial DetailsNCT06038344
Adherence, Treatment, Behavior
Edmonton, Alberta, Canada
View Trial Details